44 Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.75M Sell
35,205
-10,532
-23% -$850K 0.91% 27
2026
Q1
$3.96M Buy
45,737
+26
+0.1% +$2.49K 1.39% 9
2025
Q4
$4.39M Buy
45,711
+148
+0.3% +$14.4K 1.47% 6
2025
Q3
$4.34M Sell
45,563
-5,044
-10% -$464K 1.47% 5
2025
Q2
$4.41M Buy
50,607
+3,102
+7% +$263K 1.56% 5
2025
Q1
$4.27M Buy
47,505
+353
+0.7% +$31.6K 1.6% 6
2024
Q4
$3.77M Sell
47,152
-2,886
-6% -$250K 1.45% 6
2024
Q3
$4.62M Buy
+50,038
New +$4.21M 1.62% 5
2023
Q2
$4.09M Buy
46,406
+23,860
+106% +$2.05M 1.4% 16
2023
Q1
$1.82M Buy
22,546
+512
+2% +$41.7K 0.62% 43
2022
Q4
$1.71M Buy
22,034
+4,345
+25% +$352K 0.59% 47
2022
Q3
$1.43M Buy
17,689
+5,241
+42% +$471K 0.59% 49
2022
Q2
$1.12M Buy
+12,448
New +$1.26M 0.43% 65
2022
Q1
Sell
-6,748
Closed -$698K 180
2021
Q4
$698K Sell
6,748
-86
-1% -$9.96K 0.24% 90
2021
Q3
$857K Sell
6,834
-68
-1% -$8.8K 0.33% 76
2021
Q2
$857K Sell
6,902
-542
-7% -$68.1K 0.33% 75
2021
Q1
$879K Sell
7,444
-4,624
-38% -$542K 0.37% 66
2020
Q4
$1.41M Buy
+12,068
New +$1.33M 0.64% 37

Other funds holding MDT

44 Wealth Management's MDT Position: Q2 2026 in Review

44 Wealth Management reduced its Medtronic (MDT) stake by 23% in Q2 2026, selling an estimated $850K and leaving 35,205 shares worth $2.75M. The position accounts for 0.91% of the portfolio, ranked #27.

44 Wealth Management first reported a position in MDT in Q4 2020 and has held it in 18 quarters since. The position peaked at $4.62M in Q3 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • 44 Wealth Management held 35,205 shares of Medtronic worth $2.75M as of Q2 2026.
  • 44 Wealth Management sold 10,532 Medtronic shares in Q2 2026, an estimated $850K.
  • Medtronic made up 0.91% of 44 Wealth Management's portfolio in Q2 2026, its #27 holding.
  • 44 Wealth Management first reported a position in Medtronic in Q4 2020 and has held it in 18 quarters since.
  • 44 Wealth Management's Medtronic position peaked at $4.62M in Q3 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on 44 Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.